| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7753553 | Journal of Fluorine Chemistry | 2013 | 9 Pages |
Abstract
This account presents our recent progress, in perspective, on the strategic incorporation of fluorine(s) for the development of taxoid-based tumor-targeted drug delivery systems. Through rational design, the unique nature of fluorine has been exploited to increase the potency and metabolic stability of taxoid anticancer agents as potent warheads, to validate linker release mechanisms, and to construct PET tracers to assess the biodistribution and efficacy of tumor-targeted drug conjugates.
Related Topics
Physical Sciences and Engineering
Chemistry
Inorganic Chemistry
Authors
Joshua Seitz, Jacob G. Vineberg, Edison S. Zuniga, Iwao Ojima,